Incumbency footprint / loaded awards
MARK CUBAN COST PLUS DRUG COMPANY, PBC
Source set: USASpending · As of 2026-11-10. Coverage is limited to loaded award records.
UEI as published: N8P7MQ937WN7
Active-award and obligated rollups are withheld: the agent-written rollup has no covered period or n field. A full federal footprint is not verified.
Loaded award records
| Incumbent / award | Agency | Obligated | Source end date | Provenance |
|---|---|---|---|---|
| MARK CUBAN COST PLUS DRUG COMPANY, PBCW911SR26CA011 ↗ | Department of Defense | $1,393,259.04 | 2028-04-12Period of performance current end date (USASpending) | USASpendingCONT_AWD_W911SR26CA011_9700_-NONE-_-NONE-As of 2026-05-08 |
Upcoming source end dates
No eligible published records in this view.
Only records loaded by the operator with complete source provenance appear here.
Dates reflect the source record. Options and extensions exist; an end date does not establish that a contract will be recompeted, renewed, or terminated.